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The most influential line of reasoning in gerontology is 
known as Disposable Soma Theory (DST). In brief, the 
theory states that aging is caused by accumulation of 
random damage, which is counteracted by repair. 
Repair is costly and the organism allocates exactly the 
needed amount of energetic resources. Recently, DST 
was applied to explain why women live longer than 
men [1]. Women are less disposable than men, so they 
need a better repair and thus live longer [1].  
 
It might seem slightly repetitive that women live longer 
because they are less disposable because females need 
better health for reproduction.  I will discuss that this 
explanation is also erroneous. But to start with, the 
name of the theory (disposable soma) is ambiguous 
because soma is disposable by definition:  soma versus 
germ line.  All theories of aging are more or less 
disposable soma theories. (Footnote: according to DST 
itself, soma is not instantly disposable. It is constantly 
repaired depending on how much soma needs to be not 
be disposed of. Then soma is sort of recycled after 
constant repair). So we all agree that soma is disposable 
(by definition). The question is why is soma disposable 
and what makes it disposable. According to DST, it is 
allocation of resources from repair to other needs. Here 
 I will also discuss an alternative model. 
 
Let us consider that it is not lack of resources that 
renders soma unusable. According to TOR-centric 
model [2, 3], as one of examples, there is another cause 
that kills us first.  And this cause is not accumulation of 
random molecular damage. Yes, random damage 
accumulates with age. Yes, this eventually would make 
soma unusable. Eventually. But accumulation of 
random damage does not drive aging as we know it. 
Molecular damage does not cause that  aging  that  kills  
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us (and short-lived worms).  That aging is an aimless, 
unintended, purposeless continuation of developmental 
growth and development is not driven by damage of 
course. While development is programmed, aging, 
however, is not. It is quasi-programmed (a quasi-
program is an unintended continuation of a program that 
was not switched off after its completion [4, 5]). And 
the same signaling pathways are involved in both 
development and aging. This is a clear-cut example of 
antagonistic pleiotropy. Activation of sensing-signaling 
pathways such as the nutrient-sensing TOR (Target of 
Rapamycin) drives growth and, when it is completed, 
TOR (among other players) causes aging. Figuratively, 
cellular aging is a continuation of growth [6]. Cellular 
aging (in part by causing age-related diseases) leads to 
non-random tissue, organ and system damage, 
ultimately causing organismal death. Driven by sensing-
signaling pathways such as TOR, aging causes non-
random macro-damage, literally visible in the mirror. In 
other words, diseases of aging and organismal aging 
results from chronic hyper-activation of intracellular 
signaling pathways such as the nutrient-sensing TOR 
pathway, which is antagonized by gerossuppressors or 
genes for longevity [5]. (on genes for longevity such as 
sirtuins, AMPK and FOXO see excellent reviews and 
commentaries [7-17]). (Footnote: Also, there are TOR-
independent quasi-programs but more on this in 
forthcoming essays. Furthermore, activation of DNA-
damage responses, even without damage, is a part (but 
not central) of TOR-centric network [18]). Cellular 
aging (hyper-activation) causes organ damage. This 
links gerontology to medicine, which deals with age-
related diseases. Cellular hyper-activation (aging) via a 
chain of events - well known in medical science - 
culminates in non-random organ and systemic damage, 
for examples, damage of the heart and the brain (infarct 
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longer (unless medical interventions keep a patient 
alive). Thus, soma is instantly disposable after organ or 
systemic damage caused by cellular over-activation. 
Soma is like a car without brakes and without a driver 
too [19]. 
 
So why do women live longer? This was discussed in 
detail in the May issue of Aging [20].  In brief, high 
accidental death rate is associated with faster aging in 
different species, from worms to mammals. The same is 
applicable to longevity of males versus females. The 
accidental death rate, from accidents, violence, combat, 
is higher in young men than in women. Historically, it 
was much higher. Higher accidental death rate in young 
men may have led them to be larger and stronger than 
women. mTOR drives cellular size growth  and muscle 
hypertrophy [21-23], including testosterone-induced 
hypertrophy [24, 25]. (Noteworthy, rapamycin 
reversibly decreases levels of testosterone [26-28]).  I 
suggest that hyper-active mTOR contributes to physical 
robustness of young males, allowing them to fight and 
compete. But hyper-active mTOR is beneficial earlier in 
life at the cost of accelerated aging. Thus males might 
age faster because TOR afforded strength and mass, 
which was beneficial in young males [20]. In other 
words, accelerated aging in males relative to females 
could be a byproduct of physical robustness to prevent 
death from extrinsic causes.  Males need to be more 
robust and healthier to survive, outcompete other males 
and have a chance for reproduction. Females do not 
need such robustness (and health) to participate in 
reproduction and this is why they age slower and live 
longer. In contrast, DST postulates that females live 
longer because females need better health for 
reproduction. 
 
Both TOR-centric model and DST agree that women 
live longer not because (or not only because) “men 
drive themselves to an early grave”. However, 
according TOR-centric model, exactly because “men 
drive themselves to an early grave”, evolution favored 
their robustness early in life and accelerated aging. 
Elimination of early death also explains “why longevity 
is constantly increasing”, by allowing slow-aging 
individuals to survive” [29]. 
 
But regardless of why women live longer, this mere fact 
seems to contradict DST.  Females use more resources 
for reproduction and would be expected to have less for 
anti-aging repair. I will return to paradoxes of DST 
later.  
 
Importantly, the TOR-centric model suggests means for 
extending health span: some are novel like rapamycin 
and some are well known like ‘eating less’. According 
to the TOR-centric model, food simply activates the 
nutrient-sensing TOR pathway, which in turn drives 
aging (or growth early in life).  The more food, the 
more activated TOR, the faster aging [30].  
 
Eating less, or calorie restriction, prolongs life span in 
most animals and prevents age-related diseases in 
humans, thus extending healthy life span. This cannot 
be easily reconciled with DST [31, 32]. According to 
DST, anti-aging repair is costly and resources are 
scarce. More food intake corresponds to more calories 
available for repair. But more food intake, in contrast, 
corresponds to faster aging. To explain this observation, 
DST suggests that although repair is limited by scarce 
resources, the organism uses more resources for repair 
when resources are scarce, in order to delay aging (even 
though, according to DST, aging does not limit survival 
in the wild). Thus to explain why women live longer 
and why extra food shortens life span, classic DST was 
modified by suggesting paradoxical trade-offs and 
regulation of health depending on one’s needs. Is trade-
off between reproduction and somatic maintenance 
supported by data [33]. And does a pregnant woman 
halt DNA repair in her somatic cells? Other paradoxes 
were discussed in detail [32]. 
 
In its current form, DST implicitly contradicts 
evolutionary theory, suggesting that aging is regulated 
by choosing not to repair in the time of plenty, or 
instead repair when resources are scarce in order to live 
longer (as if aging limits lifespan in the wild) and 
reproduce later. According to DST, menopause is 
programmed to benefit both aging women and 
grandchildren. Although the grandmother hypothesis is 
extremely emotionally appealing (it provides positive 
meaning to menopause), women do not benefit from 
menopause. Simply most females did not live long 
enough in the past to experience menopause until 
recently. By its negative consequences, menopause is 
actually an age-related disease, like atherosclerosis, 
which occurs in every aging woman too. Like aging and 
atherosclerosis, menopause is not programmed and is 
not beneficial [20]. Like aging and atherosclerosis, 
menopause is quasi-programmed (an aimless 
continuation of reproductive program), an unintended 
by-product of development: the same mechanism that 
initially activates ovarian cycle later in life over-
activates the ovary causing menopause unintentionally. 
This overactivation depends in part on the TOR 
pathway (see for ref. [20]). Menopause can be viewed 
as a by-product of development [34]. Loss of oocytes 
begins before birth and continues until menopause [35].  
Proposed in the late 1970s, classic DST was not based 
on experiments but on pure logic. This is how an 
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aging must be a passive process, whereas repair is 
limited by resources, depending on the needs of the 
organism (to be more or less dispensable). This is how 
life should be designed. But life was not designed by an 
intelligent scientist. It was shaped by a blind 
watchmaker for immediate benefits [36]. And it is 
wasteful and uses extra-calories to activate the TOR 
pathway even when it signals not growth, but aging. 
  
Why is DST so popular? First, it is brilliantly presented, 
vividly written and published in most influential 
journals. As described in Scientific American “… aging 
process is caused by the gradual buildup of a huge 
number of individually tiny faults – some damage to a 
DNA strand here, a deranged protein molecule there, 
and so on”. Second, soma is disposable (according to all 
possible theories) so we all agree with the name of 
DST. But another reason for DST popularity seems to 
be that one needs no knowledge of biology or medicine 
to understand the theory. This is appealing.  In contrast, 
understanding of TOR-centric theory requires 
knowledge of molecular mechanisms of signal 
transduction, clinical and experimental medicine and 
the genetics of model organisms. But there is a pay-off: 
We can make predictions and explain observations and 
suggest a therapy. Just by drawing signaling pathways 
from insulin and nutrients to mTOR with feedback 
inhibition of insulin-signaling, we can predict that low 
insulin levels (by not activating mTOR) extend life span 
(good health), whereas low insulin responsiveness can 
be a feedback response to over-activated mTOR, which 
shortens lifespan (bad health). In contrast, DST cannot 
explain this, thus creating paradox. According to DST, 
“The real paradox is why, in mammals, low insulin 
levels are associated with good health, but low insulin 
responsiveness with bad health” [37].”  
 
Thus, even though it requires background knowledge 
and efforts from the readers, scientific gerontology must 
be in agreement with medical science, genetics of 
longevity and molecular biology of signal transduction. 
It is studying of signal transduction pathways that can 
not only explain why women live longer but also how to 
extend lifespan without the need for a “drastic remedy” 
mentioned in the Scientific American paper [1].  
 
Appendix: not comparing apples to oranges. One of 
the critiques of this essay was that “comparing DST and 
the TOR theory is like comparing apples to oranges.  
DST does not propose any molecular mechanism while 
the TOR pathway is a molecular network”. Although I 
was not intending to compare structures of the two 
theories, now I wish to add that both theories answer 
“Why and How” questions. According to DST “Why” 
is allocation of resources from anti-aging repair to other 
needs. “How” is accumulation of all sorts of random 
damage, with emphasis on molecular damage. 
(Footnote: The mechanism (How) might be different 
and, as an intellectual exercise, I can suggest another 
version of DST. For example, all tissues produce CO2 
and energetic resources are needed to breath CO2 out. 
But resources for breathing are limited. And one does 
not need to breath indefinitely; soma is disposable any 
way. This amusing version of DST - aging is caused by 
accumulation of CO2 due to limited resources- can 
seemingly make a strong case. For one, cessation of 
circulation or ventilation kills instantly. And vice versa 
ventilation of terminally ill patients extends life. Still, 
this is not a cause of aging). Having said all that, I 
would like to defend classic DST. In its original form, 
classic DST might be correct, and accumulation of 
random damage must terminate lifespan sooner or later. 
However, living beings die from another sort of aging 
first: non-random, quasi-programmed damage (mostly 
organ and systemic damage), manifested in humans as 
age-related diseases (in worm – other manifestations). 
The TOR theory, which is actually “quasi-programmed 
aging” theory also answers the questions Why and 
How. Why: Aimless continuation of genetic programs 
and processes, which are essential early in life but cause 
aging later. How:  activation of signaling pathways that 
causes cellular aging and non-random organ damage 
such as myocardial infarction. To compare apples to 
apples, TOR-centric model should be viewed as quasi-
programmed theory. And to compare oranges to 
oranges, DST is “life-long accumulation of random 
damage” theory. What is most important is not how to 
call a theory but how to suppress aging. And if aging is 
driven by processes that can be inhibited 
pharmacologically, then we may increase healthy 
lifespan in our lifetime [38].   
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